Watch LIVE the focusIR May Investor webinar with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.00
Bid: 34.50
Ask: 35.50
Change: -0.40 (-1.13%)
Spread: 1.00 (2.899%)
Open: 35.25
High: 36.00
Low: 34.90
Prev. Close: 35.30
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

13 Mar 2024 15:05

RNS Number : 7469G
Creo Medical Group PLC
13 March 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BZ1BLL44

Issuer Name

CREO MEDICAL GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Development Bank of Wales PLC

City of registered office (if applicable)

Cardiff

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

08-Mar-2024

6. Date on which Issuer notified

13-Mar-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.977200

0.000000

3.977200

14376727

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BZ1BLL44

14376727

3.977200

Sub Total 8.A

14376727

3.977200%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Development Bank of Wales Plc

DBW Investments (6) Ltd

0.878100

0.878100%

Development Bank of Wales Plc

DBW Investments (14) Ltd

0.731000

0.731000%

Development Bank of Wales Plc

DBW Investments (3) Ltd

2.368100

2.368100%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

13-Mar-2024

13. Place Of Completion

Cardiff

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
HOLEASDDFELLEFA
Date   Source Headline
8th Oct 20187:00 amRNSInvestor Open Event at Chepstow
3rd Oct 201812:14 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim results for six months ended 30 June 2018
17th Sep 20187:04 amRNSExtension of Distribution Agreement with Pentax
13th Sep 20187:00 amRNSFirst use of Speedboat in South Africa
3rd Sep 20181:34 pmRNSHolding(s) in Company
31st Aug 201811:32 amRNSHolding(s) in Company
31st Aug 201811:30 amRNSDirector/PDMR Shareholding
21st Aug 20183:59 pmRNSIssue of Equity Update - Amendment
21st Aug 20181:48 pmRNSIssue of Equity Update
20th Aug 201810:13 amRNSDirector/PDMR Shareholding
1st Aug 20181:24 pmRNSResult of General Meeting
18th Jul 20184:44 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSConditional Placing of New Ordinary Shares
9th Jul 20187:00 amRNSAgreement with First Medical Company
4th Jul 20187:00 amRNSUK Distribution Agreement with Diagmed Healthcare
2nd Jul 20187:00 amRNSMarket Update
10th May 201811:25 amRNSExercise of Options
20th Apr 20184:38 pmRNSChange of accounting reference date
20th Mar 20187:00 amRNSInterim results for six months to 31 December 2017
28th Feb 20184:32 pmRNSChange of Registered Office
12th Feb 20187:00 amRNSExercise of Options
9th Jan 20185:43 pmRNSDirector/PDMR Shareholding
22nd Dec 201712:10 pmRNSDirector/PDMR Shareholding
22nd Dec 20179:24 amRNSDirector/PDMR Shareholding
20th Dec 20171:32 pmRNSResult of AGM
29th Nov 20177:00 amRNSSpeedboat RS2 advances beyond initial pilot centre
24th Nov 201710:49 amRNSNotice of AGM
14th Nov 20177:00 amRNSFinal Results
25th Sep 20173:07 pmRNSHolding(s) in Company
18th Sep 20179:56 amRNSHolding(s) in Company
11th Sep 20172:05 pmRNSChange of Registered Office
1st Sep 20179:42 amRNSHolding(s) in Company
21st Aug 20177:00 amRNSAnnounces US FDA Approval of Speedboat RS2
29th Jun 20177:00 amRNSCreo Medical Pre-Submission 510k Confirmation
22nd Jun 20177:00 amRNSAnnounces First Patient Treated with Speedboat
4th Apr 20175:47 pmRNSDirector/PDMR Dealing
30th Mar 20177:00 amRNSCreo Medical Interim Results
24th Mar 20177:00 amRNSCreo CE Mark for microwave for Speedboat RS2
1st Mar 20177:00 amRNSAnnounces Participation in Research Programme
2nd Feb 20177:21 amRNSDirector/PDMR Shareholding
9th Dec 20167:00 amRNSCreo First Day of Dealings on AIM
17th Jun 20107:00 amRNSCity Centre Development
16th Jun 20104:00 pmRNSScheme of arrangement re Court Hearing
16th Jun 20107:00 amRNSSuspension - China Real Estate Opportunities Plc
9th Jun 201012:00 pmRNSResult of AGM
7th Jun 20101:03 pmRNSResult of EGM & Court Meeting
21st May 20107:00 amRNSPosting of Scheme Document
4th May 20104:00 pmRNSPublication of Financial Accounts
26th Apr 20107:00 amRNSUpdate on Proposed Asian Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.